MXCT vs SNA · rev $38.6M vs P/E 17, rev $5.11B
MaxCyte Inc (MXCT) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported SNA revenue for 2024-12-28 was $5.11B. Net income was $1.07B. Revenue was up 0.0% from 2023-12-30 to 2024-12-28. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
MXCT currently screens at market cap $124.3M. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the MXCT and SNA stock pages for the full models.
Not investment advice.